Imatinib provides durable molecular and cytogenetic responses in a practical setting for both newly diagnosed and previously treated chronic myelogenous leukemia: a study in nagasaki prefecture, Japan (Q79829822)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 February 2007

Language	Label	Description	Also known as
English	Imatinib provides durable molecular and cytogenetic responses in a practical setting for both newly diagnosed and previously treated chronic myelogenous leukemia: a study in nagasaki prefecture, Japan	scientific article published on 01 February 2007

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Imatinib provides durable molecular and cytogenetic responses in a practical setting for both newly diagnosed and previously treated chronic myelogenous leukemia: a study in nagasaki prefecture, Japan (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

based on heuristic

inferred from title

author name string

Emi Matsuo

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Yasushi Miyazaki

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Chizuko Tsutsumi

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Yoriko Inoue

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Reishi Yamasaki

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Tomoko Hata

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Takuya Fukushima

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Hideki Tsushima

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Daisuke Imanishi

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Yoshitaka Imaizumi

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Masako Iwanaga

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Mari Sakai

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Koji Ando

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Yasushi Sawayama

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Daisuke Ogawa

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Yasuhisa Kawaguchi

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Kazuhiro Nagai

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Kunihiro Tsukasaki

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Shuichi Ikeda

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Yukiyoshi Moriuchi

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Shinichiro Yoshida

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Miyuki Honda

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Jun Taguchi

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Yasuyuki Onimaru

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Takeshi Tsuchiya

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Masayuki Tawara

26

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Sunao Atogami

27

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Masaomi Yamamura

28

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Hisashi Soda

29

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Yoshiharu Yoshida

30

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Yuji Matsuo

31

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Hiroaki Nonaka

32

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Tatsuro Joh

33

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Yumi Takasaki

34

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Chiyuki Kawasaki

35

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Saburo Momita

36

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Itsuro Jinnai

37

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Kazutaka Kuriyama

38

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Masao Tomonaga

39

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 February 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

International Journal of Hematology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

85

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

132-139

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

https://scigraph.springernature.com/pub.10.1532/ijh97.06157

0 references

Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17321991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17321991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The development of imatinib as a therapeutic agent for chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17321991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase

1 reference

https://pubmed.ncbi.nlm.nih.gov/17321991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17321991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib mesylate in the treatment of chronic myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17321991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic Myeloid Leukemia — Advances in Biology and New Approaches to Treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/17321991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular responses in patients with chronic myelogenous leukemia in chronic phase treated with imatinib mesylate

1 reference

https://pubmed.ncbi.nlm.nih.gov/17321991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders

1 reference

https://pubmed.ncbi.nlm.nih.gov/17321991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17321991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17321991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome-positive chronic phase chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17321991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17321991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17321991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose escalation of imatinib mesylate can overcome resistance to standard-dose therapy in patients with chronic myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17321991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17321991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate

1 reference

https://pubmed.ncbi.nlm.nih.gov/17321991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comprehensive comparison of FISH, RT-PCR, and RQ-PCR for monitoring the BCR-ABL gene after hematopoietic stem cell transplantation in CML.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17321991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The importance of reporting patient recruitment details in phase III trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17321991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17321991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of imatinib mesylate for patients in the first chronic phase of chronic myeloid leukemia: results of a Japanese phase II clinical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17321991

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1532/IJH97.06157

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17321991%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79829822&oldid=1764395855"